An adolescent–adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4–6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine
- 22 January 2007
- journal article
- clinical trial
- Published by Elsevier BV in Vaccine
- Vol. 25 (6), 1121-1125
- https://doi.org/10.1016/j.vaccine.2006.09.053
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Recommended Childhood and Adolescent Immunization Schedule—United States, 2006PEDIATRICS, 2006
- Th2-Associated Local Reactions to the Acellular Diphtheria-Tetanus-Pertussis Vaccine in 4- to 6-Year-Old ChildrenInfection and Immunity, 2005
- Efficacy of an Acellular Pertussis Vaccine among Adolescents and AdultsNew England Journal of Medicine, 2005
- Pertussis — A Disease and Vaccine for All AgesNew England Journal of Medicine, 2005
- Injection-Site Reactions to Booster Doses of Acellular Pertussis Vaccine: Rate, Severity, and Anticipated ImpactPEDIATRICS, 2003
- Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigensVaccine, 2001
- Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergensClinical and Experimental Immunology, 2000
- Safety and Immunogenicity of Six Acellular Pertussis Vaccines and One Whole-Cell Pertussis Vaccine Given as a Fifth Dose in Four- to Six-Year-Old ChildrenPediatrics, 2000
- Extensive Swelling After Booster Doses of Acellular Pertussis–Tetanus–Diphtheria VaccinesPEDIATRICS, 2000
- Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of ageThe Pediatric Infectious Disease Journal, 1999